Chinese American immigrants face a higher risk of cardiovascular disease depending on length of residence and location in the U.S.
A national initiative led by the National Institutes for Mental Health is now underway to find figurative “rulers” that can accurately measure and compare the quality of the various mental health treatments available.
Here, based on her own cancer journey, Joanne Slobodien shares five bits of advice she would give others who are just starting to navigate their diagnosis and treatment plan.
UCLA has received a $120 million commitment from Dr. Gary Michelson and his wife, Alya, to kick-start the California Institute for Immunology and Immunotherapy, an innovative public-private partnership aimed at spurring breakthrough discoveries that prevent and cure diseases and catalyze economic growth and innovation in Los Angeles.
Robert Reiter, MD, is chief of the Division of Urologic Oncology and director of the UCLA Health Prostate Cancer Program at the UCLA Health Jonsson Comprehensive Cancer Center. He talks about the disease and what people need to know.
Founded in 1995, the Comprehensive Stroke Center is recognized as a world-leading center for managing cerebral vascular disease.
A new study from researchers with UCLA Health and collaborating organizations has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH).
Dr. Alice Soragni and her team developed a high throughput organoid screening platform to rapidly establish and screen 3D tumor organoids for cutaneous neurofibromas to find drugs that slow tumor growth.
A team of UCLA Health researchers has been awarded a National Institutes of Health (NIH) grant for a five-year study to determine whether school-based health centers (SBHCs) can improve health and academic outcomes for students experiencing chronic absenteeism.
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that Manuka honey could potentially be an alternative, natural option for breast cancer prevention and treatment— particularly for estrogen receptor (ER)-positive breast cancer, the most common subtype of breast cancer that accounts for about 70–80% of all breast cancer cases.
Accreditation includes a rigorous evaluation and review of every aspect of cancer care from prevention and early diagnosis to treatment, rehabilitation, and survivorship. By meeting these standards, the cancer center ensures that patients receive the highest level of care and support throughout their cancer journey.
The Brain & Behavior Research Foundation recognized Dr. Edgcomb for her research into the development of set rules to clearly identify children and adolescents with suicide-related symptoms using electronic health record data.
As students begin a new school year, school district officials across California are considering or establishing cellphone-use restrictions on campus. Their reasoning? Increased screen time, along with prolonged social media use, may disrupt the learning environment, stunt social development and harm students’ mental health, they say.
In a new study, a molecule identified and synthesized by UCLA Health researchers was shown to restore cognitive functions in mice with symptoms of Alzheimer’s disease by effectively jumpstarting the brain's memory circuitry.
Immunotherapy pioneer Dr. Antoni Ribas, professor of medicine at the David Geffen School of Medicine at UCLA and director of the tumor immunology program at the UCLA Health Jonsson Comprehensive Cancer Center, has been inducted into the 2024 Class of Fellows of the Academy of Immuno-Oncology by the Society for Immunotherapy of Cancer.
Newirth beat the odds thanks to a novel cancer vaccine developed by UCLA neurosurgeon Linda Liau, MD, PhD. And now, he’s doing everything in his power to support cutting-edge cancer research and provide extra support to individuals going through cancer treatment.
UCLA Health researchers, in collaboration with researchers from the Republic of Ireland and Northern Ireland, have received $9.5 million award from the National Institutes of Health (NIH) with support from European funding agencies — The Science Foundation Ireland (SFI) and the Public Health Agency Health & Social Care (HSC) — to study the effects of polyphenols on cognitive health and the brain-gut microbiome system.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
